FDA Drug Application (021883) for DALVANCE by DURATA THERAPS INTL

Back to FDA Applications sponsored by DURATA THERAPS INTL

Application Number021883
Product Number001
FormPOWDER;IV (INFUSION)
DosageEQ 500MG BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDALVANCE
Active IngredientDALBAVANCIN HYDROCHLORIDE



Back to FDA Applications sponsored by DURATA THERAPS INTL